Genthon, A., Nicolini, F. E., Huguet, F., Colin-Gil, C., Berger, M., Saugues, S., . . . Flandrin-Gresta, P. (2020). Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib. Oncotarget.
Stile di citazione ChicagoGenthon, Alexis, et al. "Influence of Major BCR-ABL1 Transcript Subtype On Outcome in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated Frontline With Nilotinib." Oncotarget 2020.
Citazione MLAGenthon, Alexis, et al. "Influence of Major BCR-ABL1 Transcript Subtype On Outcome in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated Frontline With Nilotinib." Oncotarget 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.